Cost-effectiveness model for a hypothetical monotherapy vs standard of care in adult patients with treatment-resistant depression

BACKGROUND: Patients with treatment-resistant major depressive disorder (TRD) have limited treatment options. We developed an early stage cost-effectiveness model of TRD to explore the potential value of a hypothetical monotherapy relative to the standard of care (SOC). The relative impacts of the m...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Si-Tien, Anderson, Ian M, Mitchell, Dominic, Johnson, Scott J, Shiozawa, Aki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421973/
https://www.ncbi.nlm.nih.gov/pubmed/30936731
http://dx.doi.org/10.2147/CEOR.S181718

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421973/
https://www.ncbi.nlm.nih.gov/pubmed/30936731
http://dx.doi.org/10.2147/CEOR.S181718

Ejemplares similares